RCUS vs SPCE · rev $258.0M vs rev $7.0M
Arcus Biosciences Inc (RCUS) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
Latest reported SPCE revenue for 2024-12-31 was $7.0M. Net income was -$346.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. SPCE currently screens at market cap $388.0M.
RCUS currently screens at market cap $885.2M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the RCUS and SPCE stock pages for the full models.
Not investment advice.